IL-6: A key player in the EGFR-TKI-resistant tumor microenvironment and its therapeutic implications (Review)IL-6：EGFR-TKI耐药肿瘤微环境中的关键参与者及其治疗意义（综述）International Journal of OncologyIF4.92026-04-011PRE
Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature ReviewCARDIOVASCULAR TOXICOLOGYIF3.72024-09-100OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向